These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13292117)

  • 1. [Effect of factor V on formation of plasma thromboplastin].
    HORDER MH; SOKAL G
    Acta Haematol; 1955 Nov; 14(5):294-302. PubMed ID: 13292117
    [No Abstract]   [Full Text] [Related]  

  • 2. The thromboplastin generation test; some practical modifications and study of the rôle of factors V and VII on the formation of plasma thromboplastin.
    VERSTRAETE M; VANDENBROUCKE J
    Acta Med Scand; 1956 Jun; 155(1):37-48. PubMed ID: 13339280
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of factor V in the formation of blood thromboplastin.
    HOUGIE C
    J Lab Clin Med; 1957 Jul; 50(1):61-8. PubMed ID: 13439267
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on the mechanism of action of proaccelerin (factor V, labile factor). I. Proaccelerin in the formation of endogenous thromboplastin].
    GOBBI F; ASCARI E; BARBIERI U
    Prog Med (Napoli); 1961 Sep; 17():580-7. PubMed ID: 13899355
    [No Abstract]   [Full Text] [Related]  

  • 5. [Research on the mechanism of action of proacclerin (factor V, labile factor). II. The reactions of proaccelerin with tissue thromboplastin].
    GOBBI F; BARBIERI U; ASCARI E
    Prog Med (Napoli); 1961 Nov; 17():735-41. PubMed ID: 13899357
    [No Abstract]   [Full Text] [Related]  

  • 6. THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE.
    COLMAN R; ALEXANDER B
    J Clin Invest; 1964 Apr; 43(4):720-7. PubMed ID: 14149923
    [No Abstract]   [Full Text] [Related]  

  • 7. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():779-87. PubMed ID: 14154695
    [No Abstract]   [Full Text] [Related]  

  • 8. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT.
    IDA M; TANAKA M
    Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922
    [No Abstract]   [Full Text] [Related]  

  • 9. [BLOOD CLOTTING FACTORS IN RENAL DISEASES].
    SATAKE K
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():767-78. PubMed ID: 14154694
    [No Abstract]   [Full Text] [Related]  

  • 10. THROMBOPLASTIN FORMATION.
    POOL JG
    Annu Rev Med; 1964; 15():215-32. PubMed ID: 14133846
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
    Fischer M; Falkensammer C
    Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor V and thrombin in the intrinsic clotting system.
    Ferguson JH; Ennis EG; Hitsumoto S; White NB
    Thromb Diath Haemorrh; 1969 Apr; 21(2):181-95. PubMed ID: 5769047
    [No Abstract]   [Full Text] [Related]  

  • 13. [BLOOD COAGULATION CHANGES AND THEIR RELATION TO THE EFFECT OF DRUGS IN HYPERTENSION].
    URBANIUK KG
    Kardiologiia; 1964; 4():45-8. PubMed ID: 14203916
    [No Abstract]   [Full Text] [Related]  

  • 14. STARCH BLOCK ELECTROPHORESIS OF PLASMA AND SERUM CLOTTING FACTORS. SEPARATION OF ACTIVATED PTC (PTC).
    SCHIFFMAN S; RAPAPORT SI; PATCH MJ
    Blood; 1965 May; 25():724-35. PubMed ID: 14282041
    [No Abstract]   [Full Text] [Related]  

  • 15. Stroma-free hemoglobin. I. Preparation and observations on in vitro changes in coagulation.
    Moss GS; DeWoskin R; Cochin A
    Surgery; 1973 Aug; 74(2):198-203. PubMed ID: 4197933
    [No Abstract]   [Full Text] [Related]  

  • 16. The anticoagulant activity of lysosomal cationic proteins from polymorphonuclear leukocytes.
    Saba HI; Roberts HR; Herion JC
    J Clin Invest; 1967 Apr; 46(4):580-9. PubMed ID: 6021205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of gestation on the blood coagulation system and diagnosis of possible disorders].
    Günter M; Gerl D; Bonow A
    Z Arztl Fortbild (Jena); 1973 Mar; 67(5):209-15. PubMed ID: 4582005
    [No Abstract]   [Full Text] [Related]  

  • 18. Cold promoted activation of factor VII. IV. Relation to the coagulation system.
    Gjonnaess H
    Thromb Diath Haemorrh; 1972 Oct; 28(2):194-205. PubMed ID: 4639653
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
    Rogner G
    Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
    He R; Xiong S; He X; Liu F; Han J; Li J; He S
    Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.